WP
DXCM icon

Woodline Partners’s DexCom DXCM Stock Holding History

Woodline Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Buy
536,702
+23,381
+5% +$1.56M 0.11% 241
2026
Q1 		$32.2M Buy
513,321
+17,751
+4% +$1.24M 0.12% 225
2025
Q4 		$32.9M Buy
495,570
+14,756
+3% +$954K 0.13% 207
2025
Q3 		$32.4M Buy
480,814
+2,415
+0.5% +$191K 0.15% 190
2025
Q2 		$41.8M Buy
478,399
+2,669
+0.6% +$209K 0.22% 130
2025
Q1 		$32.5M Sell
475,730
-338,692
-42% -$27.6M 0.21% 148
2024
Q4 		$63.3M Buy
+814,422
New +$60.3M 0.43% 51
2024
Q3 		– Sell
-83,798
Closed -$9.5M – 628
2024
Q2 		$9.5M Sell
83,798
-138,996
-62% -$17.6M 0.09% 252
2024
Q1 		$30.9M Sell
222,794
-9,594
-4% -$1.21M 0.28% 110
2023
Q4 		$28.8M Sell
232,388
-202,309
-47% -$20.7M 0.31% 97
2023
Q3 		$40.6M Buy
434,697
+230,668
+113% +$26M 0.48% 47
2023
Q2 		$26.2M Buy
204,029
+190,697
+1,430% +$23.1M 0.31% 97
2023
Q1 		$1.55M Sell
13,332
-107,125
-89% -$12M 0.02% 441
2022
Q4 		$13.6M Sell
120,457
-26,597
-18% -$2.92M 0.18% 161
2022
Q3 		$11.8M Sell
147,054
-11,359
-7% -$962K 0.17% 179
2022
Q2 		$11.8M Buy
+158,413
New +$14.5M 0.18% 158
2022
Q1 		– Sell
-4,000
Closed -$537K – 753
2021
Q4 		$537K Sell
4,000
-95,556
-96% -$13.7M 0.01% 546
2021
Q3 		$13.6M Buy
+99,556
New +$12.6M 0.22% 125
2021
Q1 		– Sell
-130,992
Closed -$12.1M – 440
2020
Q4 		$12.1M Buy
130,992
+100,348
+327% +$8.96M 0.32% 96
2020
Q3 		$3.16M Sell
30,644
-21,740
-42% -$2.27M 0.1% 154
2020
Q2 		$5.31M Sell
52,384
-16,120
-24% -$1.44M 0.21% 107
2020
Q1 		$4.61M Sell
68,504
-137,340
-67% -$8.55M 0.33% 89
2019
Q4 		$11.3M Buy
+205,844
New +$9.76M 0.46% 68

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Woodline Partners's DXCM Position: Q2 2026 in Review

Woodline Partners increased its DexCom (DXCM) stake by 4.6% in Q2 2026, buying an estimated $1.56M and bringing the position to 536,702 shares worth $36.1M. The position accounts for 0.11% of the portfolio, ranked #241.

Woodline Partners first reported a position in DXCM in Q4 2019 and has held it in 23 quarters since. The position peaked at $63.3M in Q4 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Woodline Partners held 536,702 shares of DexCom worth $36.1M as of Q2 2026.
  • Woodline Partners bought 23,381 DexCom shares in Q2 2026, an estimated $1.56M.
  • DexCom made up 0.11% of Woodline Partners's portfolio in Q2 2026, its #241 holding.
  • Woodline Partners first reported a position in DexCom in Q4 2019 and has held it in 23 quarters since.
  • Woodline Partners's DexCom position peaked at $63.3M in Q4 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.